Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095617518> ?p ?o ?g. }
- W2095617518 endingPage "4124" @default.
- W2095617518 startingPage "4114" @default.
- W2095617518 abstract "Article1 August 2002free access Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae Cintia Hongay Cintia Hongay Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA, 2115 USA Search for more papers by this author Nan Jia Nan Jia Department of Biology, Indiana University-Purdue University at Indianapolis, 723 W.Michigan Street, Indianapolis, IN, 46202 USA Search for more papers by this author Martin Bard Martin Bard Department of Biology, Indiana University-Purdue University at Indianapolis, 723 W.Michigan Street, Indianapolis, IN, 46202 USA Search for more papers by this author Fred Winston Corresponding Author Fred Winston Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA, 2115 USA Search for more papers by this author Cintia Hongay Cintia Hongay Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA, 2115 USA Search for more papers by this author Nan Jia Nan Jia Department of Biology, Indiana University-Purdue University at Indianapolis, 723 W.Michigan Street, Indianapolis, IN, 46202 USA Search for more papers by this author Martin Bard Martin Bard Department of Biology, Indiana University-Purdue University at Indianapolis, 723 W.Michigan Street, Indianapolis, IN, 46202 USA Search for more papers by this author Fred Winston Corresponding Author Fred Winston Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA, 2115 USA Search for more papers by this author Author Information Cintia Hongay1, Nan Jia2, Martin Bard2 and Fred Winston 1 1Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA, 2115 USA 2Department of Biology, Indiana University-Purdue University at Indianapolis, 723 W.Michigan Street, Indianapolis, IN, 46202 USA *Corresponding author. E-mail: [email protected] The EMBO Journal (2002)21:4114-4124https://doi.org/10.1093/emboj/cdf415 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info The Saccharomyces cerevisiae MOT3 gene encodes a nuclear protein implicated in both repression and activation of transcription. However, a mot3Δ mutation causes only mild phenotypes under normal growth conditions. To learn more about Mot3 function, we have performed a synthetic lethal screen. This screen identified PAN1, a gene required for normal endocytosis, and VPS41, a gene required for vacuolar fusion and protein targeting, suggesting a role for Mot3 in the regulation of membrane-related genes. Transcriptional analyses show that Mot3 represses transcription of ERG2, ERG6 and ERG9, genes required for ergosterol biosynthesis, during both aerobic and hypoxic growth. Chromatin immunoprecipitation experiments suggest that this repression is direct. Ergosterol has been shown to be required for endocytosis and homotypic vacuole fusion, providing a link between Mot3 and these processes. Consistent with these results, mot3Δ mutants have a number of related defects, including impaired homotypic vacuole fusion and increased sterol levels. Taken together, our data suggest that proper transcriptional regulation of ergosterol biosynthetic genes by Mot3 is important for normal vacuolar function and probably for the endocytic membrane transport system. Introduction MOT3 encodes a transcription factor that modulates the expression of a large number of genes in Saccharomyces cerevisiae. Mot3 is nuclear (Grishin et al., 1998), is rich in charged amino acids, has two Zn-fingers and binds DNA in a Zn-dependent manner (Madison et al., 1998). The Mot3 Zn-finger region is highly homologous to that of Msn2 and Msn4, two S.cerevisiae proteins involved in the stress-response pathway. MOT3 was originally identified in a genetic screen for high-copy-number suppressors of the spt3Δ mot1-24 double-mutant lethality (Madison et al., 1998) and in an unrelated screen for mutations that cause an altered response to α-factor (Grishin et al., 1998). More recently, Mot3 has been shown to repress the transcription of two genes during aerobic growth: ANB1, encoding a translation initiation factor; and DAN1, encoding a cell wall mannoprotein (Kastaniotis and Zitomer, 2000; Kastaniotis et al., 2000; Cohen et al., 2001). Mot3 has also been shown to activate transcription of CWP2, a gene encoding a cell wall protein (Abramova et al., 2001a). Thus, Mot3 can serve as both a repressor and an activator of transcription. As described in this paper, Mot3 also plays a role key in the regulation of genes required for ergosterol bio synthesis. Ergosterol is the major sterol in S.cerevisiae membranes and serves a role similar to that of cholesterol in mammalian cells. Ergosterol is required for proper fluidity and function of cellular membranes (Sturley, 2000), and it plays a role in both endocytosis (Munn et al., 1999) and homotypic vacuole fusion (Kato and Wickner, 2001). Ergosterol biosynthesis is regulated by intracellular ergosterol and oxygen levels, and some regulation is known to occur at the transcriptional level for many ERG genes (Sturley, 2000). Both cis-acting promoter elements and trans-acting factors, including the heme activator proteins Hap1 and Hap2/3/4 as well as Rox1, have been identified that affect ERG gene transcription; these findings have suggested that transcription of ERG genes is sensitive to oxygen levels (Turi and Loper, 1992; Kennedy et al., 1999; Jensen-Pergakes et al., 2001; Kennedy and Bard, 2001; Leber et al., 2001; Vik and Rine, 2001). Most recently, Upc2 and Ecm22, two direct activators of ERG2 transcription, have been identified and shown to bind to the Sterol Regulatory Element (SRE) in the ERG2 promoter (Vik and Rine, 2001). However, the mechanisms that regulate transcription of ERG genes in response to changes in ergosterol and oxygen levels remain largely unknown. The identification of Mot3 as a transcriptional regulator of ergosterol biosynthetic genes arose from efforts to understand the roles of Mot3. Mot3 is not essential for growth under several conditions tested, although mot3Δ strains exhibit many mild mutant phenotypes (Grishin et al., 1998; Madison et al., 1998). To learn more about Mot3, we conducted a screen for mutations that cause inviability in combination with a mot3Δ mutation. Mutations were identified in two genes: PAN1, involved in endocytosis; and VPS41, involved in vacuolar protein sorting and fusion (Radisky et al., 1997; Tang et al., 2000). Interestingly, we have found that mot3Δ mutants have several defects in vacuolar function as well. Although endocytosis and vacuolar protein-sorting and fusion are separate functions, they are all part of the general process known as the endocytic membrane transport system and, as such, they require many functions of the cell membranes (Munn, 2000). Therefore, we hypothesized a connection between Mot3 and genes required for membrane function. Transcription and chromatin immunoprecipitation experiments show that Mot3 is a repressor of at least three of the genes required for ergosterol biosynthesis, ERG2, ERG6 and ERG9. These results provide strong evidence that Mot3 plays an important role in proper function of the endocytic membrane transport system. Results Mutations in PAN1 and VPS41 cause synthetic lethality with a mot3Δ mutation To identify genes that are functionally related to MOT3, we performed a synthetic lethal screen for mutations that cause inviability in a mot3Δ genetic background. We screened ∼87 000 colonies and identified two candidates. These mutants display additional mutant phenotypes even in a MOT3+ background, facilitating their genetic analysis: one of the synthetic lethal mutants is temperature sensitive for growth at 37°C and both mutants are sensitive to cadmium. Genetic analyses demonstrated that the synthetic lethality with mot3Δ and the additional phenotypes co-segregated 2:2 in each case (Materials and methods), demonstrating that all of the phenotypes are caused by a single mutation in each of the candidates. Additional genetic tests showed the two new mutations to be recessive and to complement each other, suggesting that they identify two separate genes. We confirmed that these mutations are synthetically lethal with mot3Δ by two tests. First, we performed plasmid-shuffle experiments to demonstrate that the viability of the double mutants depended upon a plasmid containing MOT3+. Secondly, we separated each mutation from mot3Δ by crosses to a MOT3+ strain and reconstructed the synthetic lethality by crossing each single mutant to a mot3Δ strain. To clone the genes corresponding to the mot3Δ synthetic lethal mutations, plasmid library clones were isolated by complementation of the synthetic lethality or the temperature- and cadmium-sensitive phenotypes. The specific genes were identified by plasmid complementation with single genes and by linkage analysis. These experiments showed that the synthetic lethal mutation that causes temperature sensitivity is in PAN1 (designated pan1-151), and the other synthetic lethal mutation is in VPS41 (designated vps41-298) (Figure 1). PAN1 is an essential gene required for endocytosis (Tang and Cai, 1996; Tang et al., 1997, 2000; Wendland and Emr, 1998). VPS41 is a non-essential gene required for vacuolar protein targeting and homotypic vacuole fusion (Nakamura et al., 1997; Radisky et al., 1997; Darsow et al., 2001). Figure 1.A mot3Δ mutation is synthetically lethal with pan1-151 and vps41-298. mot3Δ (FY2070), mot3Δ vps41-298 (FY2073), mot3Δ pan1-151 (FY2072), vps41-298 (FY2075) and pan1-151 (FY2074), each carrying a URA3+MOT3+ plasmid, were grown on a YPD plate for 2 days at 30°C. The YPD plate was then replica plated onto an SC and an SC + 5-FOA plate and photographs were taken after incubation for 1 day at 30°C. Download figure Download PowerPoint The results from this synthetic lethal screen show that mot3Δ is synthetically lethal with mutations in genes required for both endocytosis and vacuolar function. Previous studies have shown that mutants defective for endocytosis are often synthetically lethal with mutations that affect vacuolar function (Munn and Riezman, 1994; Riezman et al., 1996; Wesp et al., 1997; Munn, 2000, 2001). Thus, these data suggest that Mot3 could be important for both normal endocytosis and vacuolar functions, or generally required for proper function of the endocytic membrane transport system. mot3Δ mutants have defective vacuoles To test the hypothesis that Mot3 is required for proper function of the vacuole, we examined vacuolar morphology and function, comparing wild-type and mot3Δ strains. First, to test whether mot3Δ mutants have a morphologically abnormal vacuole, we stained a MOT3+ strain and two different mot3Δ mutant strains with FM4-64, a vacuole-specific vital dye (Vida and Emr, 1995). Mutations that impair homotypic vacuole fusion result in an increase in the number of vacuolar structures per cell. The criteria used for classifying vacuole morphology phenotypes have been described previously (Banta et al., 1988). Briefly, cells with a class A or wild-type vacuolar morphology have one to three vacuoles per cell; cells with a class B morphology have more than three vacuoles per cell; and cells with a class C morphology lack any visible vacuole structure. From this analysis, the MOT3+ strain exhibited a wild-type (class A) vacuolar morphology (Figure 2), with a single vacuole visible in each cell. In contrast, the mot3Δ mutants displayed a mutant class B vacuolar morphology phenotype, with greater than three vacuoles per cell. We also stained the vps41-298 mutant, which had no detectable vacuolar structures, suggesting a class C phenotype (Figure 2). We conclude from these experiments that mot3Δ mutants have abnormal vacuoles. Figure 2.A mot3Δ mutant has a defect in homotypic vacuole fusion. Saccharomyces cerevisiae strains were grown to 1–2 × 107 cells/ml in liquid YPD, stained with FM4-64 and visualized as described in Materials and methods. At least 100 cells were examined for each strain and the percentage that had the phenotype shown is as follows: wild type (FY2066), 95% class A; mot3Δ (FY2069), 78% class B; mot3Δ (FY2071), 82% class B; vps41-298 (FY2075), 100% class C. Download figure Download PowerPoint To test whether the aberrant vacuolar morphology exhibited by mot3Δ mutants correlated with a defect in vacuolar function, we assayed the ability of these mutants to grow in alkaline media. One important function of the yeast vacuole is to maintain a neutral intracellular pH (Klionsky et al., 1990). Therefore, mutants with a defective vacuole are unable to grow well in media buffered at either extreme acidic or alkaline pH (Klionsky et al., 1990). Indeed, the mot3Δ mutants grew poorly on solid alkaline buffered medium, similar to the defect we observed for the vps41-298 mutant (Figure 3) and vps41Δ (data not shown). Therefore, mot3Δ mutants are defective for vacuolar function. This phenotype of mot3Δ cells is fully complemented by providing MOT3+ on a plasmid. In addition, the pan1-151 mutant is unable to grow on alkaline buffered medium and its defect is as severe as that seen for a previously characterized vacuolar mutant, vma2Δ (Anraku et al., 1992). VMA2 encodes the regulatory subunit of the vacuolar ATPase (Anraku et al., 1992). These results, taken together with the aberrant vacuolar morphology of mot3Δ mutants, strongly suggest that Mot3 is important for homotypic vacuole fusion and proper vacuolar functions. Figure 3.A mot3Δ mutant is defective for growth at pH 8. Wild-type (FY2066), vps41-298 (FY2075), pan1-151 (FY2074), mot3Δ (FY2070), vma2Δ (FY2076) and mot3Δ (FY2070) with a URA3+ MOT3+ plasmid (pMOT3+) were tested for growth on YPD and YPD pH 8 plates by spot tests (see Materials and methods). To prevent growth of sensitive strains due to media acidification by growth from neighboring resistant strains, wild-type and mot3Δ+pMOT3+ were grown on a separate YPD pH 8 plate. YPD plates were photographed after 2 days of incubation at 30°C. YPD pH 8 plates were photographed after 6 days of incubation at 30°C. Download figure Download PowerPoint Mot3 represses expression of ERG2, ERG6 and ERG9 Mot3 is nuclear (Grishin et al., 1998) and has been shown to act as a repressor and an activator of transcription (Grishin et al., 1998; Madison et al., 1998; Kastaniotis et al., 2000; Abramova et al., 2001a; Cohen et al., 2001). Therefore, the mot3Δ synthetic lethal phenotypes and defects in vacuolar function are probably due to improper transcription of genes, such as those encoding proteins required for vacuolar function or vacuolar membrane fusion. To assess this possibility, we performed microarray analyses comparing mRNA from mot3Δ and wild-type strains. The results from these experiments showed minor (<1.5-fold) effects on the mRNA levels of many genes involved with vacuolar function (VPS, VAM and VMA genes; data not shown) and cell wall biosynthesis (PAU, DAN and TIR genes; data not shown). However, a more significant effect was observed on the mRNA levels of ERG2, ERG6 and ERG9, genes encoding ergosterol biosynthetic enzymes. The mRNA levels of these genes were increased in the mot3Δ mutant (data not shown). To confirm the microarray results, northern analyses were performed. These results show that ERG2, ERG6 and ERG9 mRNA levels were elevated ∼2.5-fold in mot3Δ mutants compared with wild-type strains (Figure 4), suggesting that Mot3 is a repressor of these ERG genes. Figure 4.ERG2, ERG6 and ERG9 mRNA levels are increased in mot3Δ mutants. (A) Representative northern analyses are shown of RNA prepared from wild-type (FY2066 and FY2068), mot3Δ (FY2069 and FY2071), erg2Δ (FY2077), erg2Δ mot3Δ (FY2078), erg6Δ (FY2079) and erg6Δ mot3Δ (FY2080) strains, probed for ERG2, ERG6, ERG9, DAN1 and ACT1 mRNAs. (B) Histograms showing the relative average mRNA levels for the genes indicated, normalized to the level of ACT1 mRNA. The values and standard errors are from seven independent experiments. Download figure Download PowerPoint Previous studies suggest that ERG genes are tightly regulated at the transcriptional level, particularly in the later steps of the ergosterol biosynthetic pathway, through an uncharacterized feedback loop that ensures proper ergosterol levels (Sturley, 2000). Consistent with this model, it has been shown that mutations in some ERG genes affect the transcription of other ERG genes (Lees et al., 1995; Arthington-Skaggs et al., 1996; Smith et al., 1996; Kennedy et al., 1999). Therefore, we also tested for double-mutant phenotypes when mot3Δ was combined with erg2Δ and erg6Δ mutations (ERG9 is essential for aerobic growth, preventing similar tests with an erg9Δ mutation). As shown in Figure 4, ERG9 mRNA levels were increased in erg2Δ and erg6Δ mutants compared with wild-type levels. In the erg2Δ mot3Δ and erg6Δ mot3Δ double mutants, there is an additive effect as ERG9 mRNA levels are higher than in the single mutants. In addition, since ERG2 and ERG6 have been shown to be required for endocytosis (Munn et al., 1999; Munn, 2001), vacuolar fusion (Kato and Wickner, 2001) and growth in alkaline buffered media (Figure 5A), we tested for other phenotypes in the double mutants. Our results show that erg2Δ mot3Δ and erg6Δ mot3Δ double mutants had a more severe growth defect than the single mutants on YPD at 39°C and on alkaline buffered YPD (Figure 5A). In conclusion, there is a strong genetic interaction of MOT3 with ERG2 and ERG6, supporting a role for Mot3 in the normal transcriptional regulation of these genes required for proper ergosterol homeostasis. Figure 5.Genetic interactions of mot3Δ with erg2Δ and erg6Δ. (A) Wild-type (FY2066), erg2Δ (FY2077), erg6Δ (FY2079), mot3Δ (FY2069), erg2Δ mot3Δ (FY2078), erg6Δ mot3Δ (FY2080), vma2Δ (FY2076) and mot3Δ (FY2069) carrying a URA3+ MOT3+ plasmid (pMOT3+) strains were tested for growth on YPD and YPD pH 8 by spot tests (see Materials and methods). YPD plates were photographed after 2 days of incubation. YPD pH 8 plates were photographed after 6 days incubation. (B) Nystatin resistance of mot3Δ mutants. Wild-type (FY2066), mot3Δ (FY2069) and erg2Δ (FY2077) strains were tested for growth on YPD and YPD-nystatin plates. The YPD plate was photographed after 1 day of incubation at 30°C and the YPD-nystatin plates were photographed after 2 days of incubation at 30°C. Download figure Download PowerPoint Ergosterol is not synthesized during anaerobic growth because oxygen is a cofactor for some of the ergosterol biosynthetic enzymes (Kennedy et al., 1999; Sturley, 2000). There is also evidence that oxygen levels control transcription of some of the genes required for ergosterol biosynthesis (Thorsness et al., 1989; Kennedy et al., 1999; Sturley, 2000; Kennedy and Bard, 2001). Therefore, we tested whether ERG2, ERG6 and ERG9 mRNA levels are altered during hypoxic growth and whether Mot3 plays a role under this growth condition. Our results show that, indeed, there was a >10-fold repression of ERG2 and ERG6 mRNA levels under hypoxic conditions (Figure 6). ERG9 mRNA levels were only decreased 2-fold during hypoxic growth (data not shown), in agreement with previous studies (M'Baya et al., 1989; Kennedy et al., 1999). In a mot3Δ background, the repression of ERG2 and ERG6 under hypoxic conditions was almost completely abolished (Figure 6). These results, then, show that Mot3 is required for the strong hypoxic repression of ERG2 and ERG6 transcription. Figure 6.Mot3 is required for hypoxic repression of ERG2 and ERG6. A representative northern analysis is shown of RNA prepared from aerobically and hypoxically grown wild-type (FY2066) and mot3Δ (FY2071) cells, probed for ERG2, ERG6, DAN1 and ACT1 transcripts. The numbers indicate the average values from three independent experiments, normalized to either the wild-type strain grown aerobic ally (for ERG2 and ERG6) or to the wild-type strain grown hypoxically (for DAN1). Standard deviations were <2%. Download figure Download PowerPoint mot3Δ mutants have increased sterol levels To test whether the increased levels of ERG2, ERG6 and ERG9 mRNAs in aerobically grown mot3Δ mutant cells affect sterol levels, we performed total sterol analyses on wild-type and mot3Δ cells. As shown in Table I, mot3Δ mutants have 21% more total sterols and 15% more ergosterol than wild-type cells. Despite this modest increase in total sterols and ergosterol, mot3Δ mutants are slightly resistant to nystatin (Figure 5B), a phenotype indicative of reduced ergosterol in plasma membrane (Lorenz and Parks, 1991). As nystatin primarily binds ergosterol, most erg mutants unable to synthesize ergosterol are resistant to nystatin (McLean-Bowen and Parks, 1982; Kovac et al., 1987). Taken together, these results suggest that there is a positive correlation between increased mRNA levels of these ERG genes and an increase in total sterol production in mot3Δ mutants; however, mot3Δ mutants probably have a reduced level of ergosterol in their plasma membranes (see Discussion). Table 1. Sterol levels in mot3Δ mutants Relevant genotype Total sterol % increase Total ergosterol % increase MOT3+ 6.75 ± 0.26 – 4.27 ± 0.17 – mot3Δ 8.16 ± 0.23 21 4.92 ± 0.24 15 The total sterol and ergosterol levels are reported as μg sterol/g yeast dry weight (see Materials and methods) of wild-type (FY2066) and mot3Δ (FY2069) cells. Values represent the average and standard deviations from three independent experiments. Overexpression of UPC2 and ECM22 causes a defect in vacuolar morphology We observed a homotypic vacuole fusion defect in mot3Δ mutants, which have elevated ERG2, ERG6 and ERG9 mRNA levels compared with wild-type cells. To test whether the increased ERG gene transcription observed in mot3Δ mutants is responsible for the vacuolar defect, we increased ERG mRNA levels in a MOT3+ background. To do this we took advantage of the recent finding that overexpression of UPC2 and ECM22 causes increased ERG2 expression (Vik and Rine, 2001). Our results (Figure 7) show that a wild-type strain that contains UPC2, ECM22, or both genes on high-copy-number plasmids, had abnormal (class B) vacuolar morphology. In these experiments, ERG2 and ERG9 mRNA levels were increased ∼2-fold, while ERG6 mRNA levels were not significantly affected (data not shown). Thus, the increased expression of these ERG genes in mot3Δ mutants is likely to contribute to the mot3Δ vacuolar defect. Figure 7.Overexpression of UPC2, ECM22, or both, causes a vacuolar defect. High-copy-number plasmids carrying either UPC2, ECM22 or no insert were used to transform the MOT3+ strain FY2066 to either Ura+, Leu+ or Ura+ Leu+, respectively. Transformants were selectively grown and then stained with FM4-64 (see Materials and methods). The percentage of plasmid-containing cells that had the vacuolar phenotype shown above is as follows: ECM22, 71% class B; UPC2, 70% class B; EMC22 and UPC2, 75% class B; the plasmid control, 78% class A. Download figure Download PowerPoint Mot3 binds to the promoter regions of ERG2 and ERG6 in vivo To test whether Mot3 acts directly in repression, we performed chromatin immunoprecipitation experiments. The strongest cases of Mot3 repression that we have observed are of ERG2 and ERG6 during hypoxic growth, and we found a cluster of putative Mot3 consensus binding sites in the regulatory regions of these genes (Figure 8A). Therefore, we examined Mot3 binding to the ERG2 and ERG6 regulatory regions in cells grown in hypoxic conditions. In these experiments, we used a version of Mot3 fused to the myc-epitope tag. Our results (Figure 8B and C) demonstrate specific chromatin immunoprecipi tation of the ERG2 and ERG6 promoter regions. These chromatin immunoprecipitation results, combined with the DNA binding properties of Mot3, the presence of Mot3 binding sites, and derepressed ERG2 and ERG6 transcription in mot3Δ mutants, strongly suggest that Mot3 directly represses ERG2 and ERG6 transcription. Figure 8.Mot3 binds to the promoter region of ERG2 and ERG6 in vivo. (A) Diagram of the ERG2 and ERG6 promoter regions. The short-thin vertical lines represent the positions of the Mot3 consensus binding site sequences [(C/T/A)AGG(T/A/C/G)(T/A)] and the short thick horizontal bar represents the position of the PCR product assayed in the chromatin immunoprecipitation experiments. (B) Chromatin immunoprecipitation was performed with extracts prepared from hypoxically grown Mot3-Myc18 (FY2081) and untagged (FY1339) cells. The abbreviations used indicate the input DNA (In) and immunoprecipitated DNA (Ip) used for PCR using primers that amplify the regions defined in (A). For input DNA, 2× and 1× indicate 1/500 and 1/1000 dilutions of the chromatin solution, respectively. For immunoprecipitated DNA, 2× and 1× indicate 1/10 and 1/20 dilutions of the immunoprecipitated chromatin solution, respectively. The non-specific control used in the reactions is described in Materials and methods. (C) A histogram showing the average values and their standard errors (% IP), calculated as previously described (Larschan and Winston, 2001), from three independent experiments. Download figure Download PowerPoint Discussion Our studies have demonstrated two new and related findings about the transcription factor Mot3: (i) Mot3 is required for normal vacuolar morphology and function; and (ii) Mot3 is a transcriptional repressor of the ERG2, ERG6 and ERG9 genes. These conclusions are based on several results. First, a genetic screen discovered synthetic lethality between mot3Δ and mutations in PAN1 and in VPS41, genes required for endocytosis (Tang and Cai, 1996; Wendland et al., 1996; Tang et al., 1997, 2000; Wendland and Emr, 1998) and for vacuolar protein targeting and fusion (Nakamura et al., 1997; Radisky et al., 1997), respectively. Previous studies have shown that mutations that affect vacuolar functions are frequently lethal in combination with mutations that impair endocytosis (Munn and Riezman, 1994; Munn, 2000, 2001). Secondly, mot3Δ mutants have defects in vacuolar function and morphology. Thirdly, mot3Δ mutants have increased levels of the ERG2, ERG6 and ERG9 mRNAs under both aerobic and hypoxic conditions. Fourthly, the repression of ERG2 and ERG6 by Mot3 appears to be direct, as chromatin immunoprecipitation experiments have shown Mot3 to be physically present at their promoters. Finally, mot3Δ mutants have increased sterol levels, consistent with the conclusion that Mot3 represses the transcription of these ERG genes. Taken together, these results suggest that Mot3 plays a critical role in a transcriptional regulatory system that modulates ergosterol levels to ensure a normal endocytic membrane transport system. Although Mot3 has previously been implicated in the regulation of several different classes of genes (Grishin et al., 1998; Kastaniotis et al., 2000; Abramova et al., 2001a,b; Cohen et al., 2001), our results suggest that it is the defective repression of ERG genes that causes the vacuolar defects observed in mot3Δ mutants. This conclusion is based on our finding that when ERG genes are overexpressed in a MOT3+ genetic background, we observed vacuolar defects similar to those observed in mot3Δ mutants. Although we cannot rule out that the defect in homotypic vacuolar fusion caused by mot3Δ or by overexpression of UPC2 and ECM22 is due to other pleiotropic effects, we do observe similar effects on ERG2 and ERG9 mRNA levels in the two different situations. Recent studies have shown that ergosterol is required for homotypic vacuolar fusion (Kato and Wickner, 2001). Our work provides the first evidence that transcriptional regulation of genes required for ergosterol biosynthesis plays a significant role in vacuolar functions. The fact that ergosterol is also required for normal endocytosis (Munn et al., 1999) suggests that Mot3 is also required for this aspect of the endocytic membrane transport system. Increased ERG gene expression in mot3Δ mutants and vacuolar defects Our results have demonstrated that in mot3Δ mutants there is an increased level of ERG gene mRNAs and an increased level of sterols. However, mot3Δ mutants have a vacuolar defect similar to those observed in mutants defective in ergosterol synthesis (Kato and Wickner, 2001), an apparently opposite situation. The mild nystatin resistance of mot3Δ mutants suggests that the increased expression of ERG genes in mot3Δ mutants may actually result in a reduced level of ergosterol in the plasma membrane. There are several possibilities for how increased ERG gene expression might reduce the level of functional ergosterol and impair vacuolar morphology and function. For example, the increased level of ergosterol might accumulate in an aberrant form, thereby reducing the level of ergosterol available for membranes. This possibility is supported by the observation that mot3Δ mutants have an elevated level of lipid particles (M.Valachovic and M.Bard, unpublished results). Previous studies have shown that a common mechanism for disposing of excess intracellular sterol is sterol esterification and deposition into such lipid particles (Soustre et al., 1998; Zweytick et al., 2000). Therefore, the increased level of sterols in mot3Δ mutants might activate this mechanism of disposal, resulting in abnormal sterol trafficking, which has been correlated with an abnormal sterol composition of vacuol" @default.
- W2095617518 created "2016-06-24" @default.
- W2095617518 creator A5055187666 @default.
- W2095617518 date "2002-08-01" @default.
- W2095617518 modified "2023-10-07" @default.
- W2095617518 title "Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae" @default.
- W2095617518 cites W1507194301 @default.
- W2095617518 cites W1648080802 @default.
- W2095617518 cites W1788218850 @default.
- W2095617518 cites W1913497294 @default.
- W2095617518 cites W1915945057 @default.
- W2095617518 cites W1936931129 @default.
- W2095617518 cites W1968633942 @default.
- W2095617518 cites W1969583685 @default.
- W2095617518 cites W1975732952 @default.
- W2095617518 cites W1984354326 @default.
- W2095617518 cites W1988192966 @default.
- W2095617518 cites W1992659479 @default.
- W2095617518 cites W1996872353 @default.
- W2095617518 cites W1998179008 @default.
- W2095617518 cites W1999899846 @default.
- W2095617518 cites W1999916089 @default.
- W2095617518 cites W2002192641 @default.
- W2095617518 cites W2004281842 @default.
- W2095617518 cites W2004961601 @default.
- W2095617518 cites W2019215631 @default.
- W2095617518 cites W2024986501 @default.
- W2095617518 cites W2028967650 @default.
- W2095617518 cites W2045790079 @default.
- W2095617518 cites W2052562460 @default.
- W2095617518 cites W2054919319 @default.
- W2095617518 cites W2063090570 @default.
- W2095617518 cites W2064680930 @default.
- W2095617518 cites W2090502005 @default.
- W2095617518 cites W2091767998 @default.
- W2095617518 cites W2095771622 @default.
- W2095617518 cites W2099034328 @default.
- W2095617518 cites W2100649212 @default.
- W2095617518 cites W2100716254 @default.
- W2095617518 cites W2104140801 @default.
- W2095617518 cites W2106645421 @default.
- W2095617518 cites W2108552532 @default.
- W2095617518 cites W2109300916 @default.
- W2095617518 cites W2112866008 @default.
- W2095617518 cites W2116521209 @default.
- W2095617518 cites W2117199571 @default.
- W2095617518 cites W2118211098 @default.
- W2095617518 cites W2125452667 @default.
- W2095617518 cites W2130264382 @default.
- W2095617518 cites W2130451172 @default.
- W2095617518 cites W2132042764 @default.
- W2095617518 cites W2134890600 @default.
- W2095617518 cites W2140948740 @default.
- W2095617518 cites W2141260639 @default.
- W2095617518 cites W2144029424 @default.
- W2095617518 cites W2152231771 @default.
- W2095617518 cites W2159424335 @default.
- W2095617518 cites W2160849328 @default.
- W2095617518 cites W2163476686 @default.
- W2095617518 cites W2165079759 @default.
- W2095617518 cites W2166647018 @default.
- W2095617518 cites W2167347342 @default.
- W2095617518 cites W2169333620 @default.
- W2095617518 cites W2183630872 @default.
- W2095617518 cites W2186230891 @default.
- W2095617518 cites W2215618176 @default.
- W2095617518 cites W2254451477 @default.
- W2095617518 cites W2323434140 @default.
- W2095617518 cites W53374033 @default.
- W2095617518 doi "https://doi.org/10.1093/emboj/cdf415" @default.
- W2095617518 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/126159" @default.
- W2095617518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12145211" @default.
- W2095617518 hasPublicationYear "2002" @default.
- W2095617518 type Work @default.
- W2095617518 sameAs 2095617518 @default.
- W2095617518 citedByCount "68" @default.
- W2095617518 countsByYear W20956175182012 @default.
- W2095617518 countsByYear W20956175182013 @default.
- W2095617518 countsByYear W20956175182014 @default.
- W2095617518 countsByYear W20956175182015 @default.
- W2095617518 countsByYear W20956175182017 @default.
- W2095617518 countsByYear W20956175182018 @default.
- W2095617518 countsByYear W20956175182020 @default.
- W2095617518 countsByYear W20956175182021 @default.
- W2095617518 countsByYear W20956175182022 @default.
- W2095617518 countsByYear W20956175182023 @default.
- W2095617518 crossrefType "journal-article" @default.
- W2095617518 hasAuthorship W2095617518A5055187666 @default.
- W2095617518 hasBestOaLocation W20956175181 @default.
- W2095617518 hasConcept C104317684 @default.
- W2095617518 hasConcept C14036430 @default.
- W2095617518 hasConcept C150194340 @default.
- W2095617518 hasConcept C158448853 @default.
- W2095617518 hasConcept C2777576037 @default.
- W2095617518 hasConcept C2777910421 @default.
- W2095617518 hasConcept C2778447961 @default.
- W2095617518 hasConcept C2910135453 @default.
- W2095617518 hasConcept C54355233 @default.